Kan. Admin. Regs. § 28-35-135g - Definitions
As used in these regulations, each of the following terms shall have the meaning assigned in this regulation:
(a) "Gantry" means that part of the system
supporting and allowing possible movements of the radiation head.
(b) "General emergency" means that an
accident has occurred or is in progress, involving actual or imminent
catastrophic reduction of facility safety systems with the potential for loss
of containment or confinement integrity or release of radioactive material that
can be reasonably expected to exceed off-site protective action guides.
(c) "Generally applicable
environmental radiation standards" means standards issued by the U.S.
environmental protection agency (EPA) under the authority of the atomic energy
act of 1954, as amended, that impose limits on radiation exposures or levels,
or concentrations or quantities of radioactive material, in the general
environment outside the boundaries of locations under the control of persons
possessing or using radioactive material.
(d) "General purpose radiographic X-ray
system" means any radiographic X-ray system that, by design, is not limited to
the radiographic examination of specific anatomical regions.
(e) "Gonadal shield" means a protective
barrier for the testes or ovaries.
(f) "Gray (Gy)" means the SI unit of absorbed
dose. One gray is equal to an absorbed dose of one joule per kilogram. One gray
is also equal to 100 rads.
(g)
"Group I" means prepared radiopharmaceuticals that are used for diagnostic
studies involving measurements of uptake, dilution, and excretion, as specified
in 10 CFR
35.100, which is adopted by reference in
KA.R. 28-35-264.
(h) "Group II"
means prepared radiopharmaceuticals that are used for diagnostic studies
involving imaging and tumor localizations and any radioactive material in a
radiopharmaeutical prepared from a group II kit or providing a single dose.
With respect to radiopharmaceuticals prepared from group II kits or as single
doses, group II shall refer to the unsealed byproduct material specified in
10 CFR
35.200, which is adopted by reference in
K.A.R. 28-35-264.
(i) "Group III"
means generators and reagent kits that are used following the manufacturer's
instructions for the preparation of diagnostic radiopharmaceuticals. With
respect to generators and reagent kits, group III shall refer to the unsealed
byproduct material specified in
10 CFR
35.200, which is adopted by reference in
K.A.R. 28-35-264.
(j) "Group IV"
means prepared radiopharmaceuticals that are used for certain therapeutic uses
that do not normally require hospitalization for purposes of radiation safety.
With respect to uses that do not normally require hospitalization, group IV
shall refer to the unsealed byproduct material specified in
10 CFR
35.300, which is adopted by reference in
K.A.R. 28-35-264.
(k) "Group V"
means prepared radiopharmaceuticals for certain therapeutic uses that normally
require hospitalization for purposes of radiation safety. With respect to uses
that normally require hospitalization, group V shall refer to unsealed
byproduct material specified in
10 CFR
35.300, which is adopted by reference in
K.A.R. 28-35-264.
(l) "Group VI"
means sources and devices containing radioactive material used for medical
diagnosis and therapy, as specified in
10 CFR
35.400, which is adopted by reference in
K.A.R. 28-35-264.
(m) "Guide tube"
means a flexible or rigid tube for guiding the source assembly and the attached
control cable from the exposure device to the exposure head. This term may
include the connections necessary for attachment to the exposure device and to
the exposure head.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.